In Teva vs. GSK skinny label feud, Biden admin urges Supreme Court to weigh in Lilly's early data on next-gen Alzheimer's drug show 'robust' amyloid reduction but a familiar adverse event David Liu's lab shows new base editing SMA therapy could lead to a one-time therapy J&J proposes $8.9B talc settlement deal but some plaintiffs decry 'woefully inadequate' offer How much does a biotech pay? Community-generated data tool gives a peek at industry's salaries FDA grants medical device clearance to Snoo robotic baby bassinet Ahead of Pfizer buyout, Seagen's Padcev gains Keytruda combo nod in first-line bladder cancer Sumitomo Pharma tidies up 7 units into one combined US entity in spring cleaning In $2.6B cell and gene therapy expansion, Sartorius buys viral vector specialist Polyplus Gaps in public info on cancer drugs and 'potentially misleading' details spur call for regulatory actions | 